Treatment of chronic ureaplasma infection with bioresonance and frequency therapy

AUTHORS : Ovchinnikov V.G., Akimova G.V.

RELEVANT UNIVERSITIES : Moscow Herpetic Center, Moscow, Russia

YEAR : 2005 | Category : Method of Treatment

Ureaplasma (t-mycoplasma) occupies a leading place among sexually transmitted infections. It is a polymorphic microorganism with a three-layer cytoplasmic membrane 130-200 nm in size, capable of intracellular reproduction. There are 14 known serotypes of ureaplasmas, which are divided into 2 biovars: the Parvo biovar includes 4 serotypes (1, 3, 6, 14), the T-960 biovar – the remaining 10 serotypes.

Ureaplasma is transmitted by contact to household, incl. sexually, with the latter being the most common. A vertical route of transmission is also possible, which can be carried out as a result of an ascending infection from the vagina and cervical canal. Intrauterine route of infection: if there is an infection in the amniotic fluid, the fetus becomes infected through the digestive tract, skin, eyes, urogenital tract. For men, ureaplasmosis is an exclusively genital infection.

The incidence of urealasma infection is about 25% with colpitis and reaches 35-40% with cervical erosions. Mycoplasma carriage during pregnancy and inflammatory processes of the genitals reaches 90%. Among gynecological patients, ureaplasma is secreted in 55% of cases, and among clinically healthy women in 45% of cases, in girls – 8%, in elderly women – 4%. Latent ureaplasma infection poses a great potential danger, since under certain conditions (for example, during pregnancy) it can become more active and cause severe inflammatory processes.

Often, ureaplasma can be a “conductor” of viruses and be accompanied by concomitant microflora (gram-positive and gramnegative bacteria), Trichomonas, gardnerella, chlamydia. We have treated 32 patients aged 23 to 56 years (30 women and 2 men) with chronic ureaplasma infection, isolated for the first time more than 2 years ago, and underwent 3 to 8 courses of combined antibiotic therapy and immunocorrection. The hardware and software complex “IMEDIS-EXPERT” was used for therapy and selection of drugs. Control of recovery was carried out by the method of culture diagnostics with titration and PCR 5-7 days after the end of the course of treatment.